Physician profile
Andrew E Leake
NPI 1730405127
$17,182.59
in general payments reported to CMS, 2019-2025
14 companies · $691 in 2025
The $691 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $620 · 2020: $437 · 2021: $116 · 2022: $5,053 · 2023: $8,109 · 2024: $2,158 · 2025: $691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $9,250 · Food and Beverage: $1,707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $9,250.00 |
| Food and Beverage | $1,707.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $13,862.65 | 2022-2024 | Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $851.05 | 2022-2025 | Endurant Iis, Venaseal, Abre |
| Philips North America LLC | $622.67 | 2023-2025 | IV Other, Igt Devices Systems Undivided, Intrasight 2 Mobile |
| Penumbra, INC. | $485.77 | 2020-2025 | Indigo System, Penumbra System |
| W. L. Gore & Associates, INC. | $313.47 | 2019-2023 | Gore Tag Thoracic Endoprosthesis |
| Silk Road Medical, INC. | $266.91 | 2019-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Medtronic Vascular, INC. | $252.86 | 2019 | |
| Cook Medical LLC | $252.04 | 2019-2020 | |
| Abbott Laboratories | $90.56 | 2020 | |
| Bard Peripheral Vascular, INC. | $64.47 | 2021 | |
| Janssen Pharmaceuticals, INC | $56.41 | 2020-2022 | |
| Baxter Healthcare | $28.45 | 2022 | |
| Lemaitre Vascular, INC. | $21.76 | 2022 | |
| Becton, Dickinson and Company | $13.52 | 2025 | Denali Vena Cava Filter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Leake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.